Antares Pharma Inc. (AIS) News

News for Antares Pharma Inc.  (AIS) 
Sector News | Topic News
$ 2.59   -0.09 (-3.36%) Volume: 1.26 m 4:00 PM EST Feb 10, 2012
After Hours:  $ 2.59 0.00 (0.00%) Volume: 4.54 k 5:15 PM EST Feb 10, 2012
View News From:  
Wed, Jan 25, 2012
8:20 AM Antares Pharma and Boston Scientific Benefit From Renewed Industry Optimism - Marketwire
Tue, Jan 17, 2012
8:00 AM Antares Pharma Enters Licensing Agreement with Daewoong Pharmaceuticals Co. Ltd. for Oxybutynin Gel 3% in South Korea - Business Wire
Tue, Dec 20, 2011
9:00 AM Antares Pharma Enters Licensing Agreement with Pfizer Consumer Healthcare - Business Wire
Fri, Dec 16, 2011
8:16 AM Recent FDA Approvals for Antares Pharma and Boston Scientific Have Done Little to Boost Shares - Marketwire
Mon, Dec 12, 2011
10:30 AM Antares Pharma to Present at the Oppenheimer 22nd Annual Healthcare Conference - Business Wire
Thu, Dec 08, 2011
7:00 AM Antares' Oxybutynin Gel Product Approved by FDA for the Treatment of Overactive Bladder - PR Newswire
Thu, Dec 01, 2011
8:16 AM Antares Pharma and Radient Pharmaceuticals See Uptick in Demand - Marketwire
Tue, Nov 29, 2011
8:00 AM Antares Pharma Announces Issuance of New U.S. Patent Covering LibiGel® - Business Wire
Mon, Oct 24, 2011
8:16 AM Highly Scrutinized Medical Equipment and Supplies Sector Looks for FDA Clarity - Marketwire
Thu, Sep 22, 2011
8:16 AM Medical Supply Makers Look for FDA Clarity - Marketwire
Tue, Sep 06, 2011
7:30 AM Unilife Develops Proprietary Self-Injection System - Marketwire
Mon, Aug 15, 2011
8:16 AM Radient and Antares Pharmaceuticals Navigate More Scrutiny - Marketwire
Wed, Jun 15, 2011
8:16 AM Medical Supplies Sector Seeks FDA Clarity - Marketwire
Fri, Jun 10, 2011
9:00 AM Pharmaceuticals Write Positive Prescription -- Research Report on Antares Pharma, Inc. and Teva Pharmaceutical Industries Limited - Marketwire
Fri, Feb 11, 2011
9:59 AM Investors will look closely at data from Libigel update presentation - Accesswire
 

NYE - Equity | NYE - ETF | AMX - Equity | AMX - ETF | NSD - Equity | NSD - ETF
NMF - ETF | NMF - Money Market Fund | NMF - Mutual Fund | OTC - Equity | OTO - Equity | OTO - ETF | OTO - Mutual Fund
CNQ - Equity | CBO - Equity | BDM - Equity | TSX - Equity | TSX - ETF | TSX - Mutual Fund | TSV - Equity | TSV - Mutual Fund

Dow Jones Composite Index | Dow Jones Industrial Avg | Dow Jones Transportation Avg | Dow Jones Utiliy Index | NASDAQ 100
Russell 1000 | Russell 2000 | Russell 3000 | Russell Microcap | Russell Midcap | S&P 500 | S&P MidCap 400 | S&P/TSX 60 | S&P/TSX MidCap

Recently Added Symbols   Firms   Find Financial Advisors

Advisors by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

RIAs by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Tags: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Insiders: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.

Copyright © 2010 InvestorPoint.com All rights reserved.